Editorial Comment by Ulmert, D, Lilja, H

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. by Lilja, H, Ulmert, D, Vickers, A

Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278)) by Lilja, H, Ulmert, D, Vickers, A

Prostate kallikrein markers in diagnosis, risk stratification and prognosis. by Ulmert, D, O'Brien, M, Bjartell, A, Lilja, H

Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening. by Savage, C, Lilja, H, Cronin, A, Ulmert, D, Vickers, A

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C. by Ulmert, D, Becker, C, Nilsson, J, Piironen, T, Björk, T, Hugosson, J, Berglund, G, Lilja, H

The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy. by Vickers, A, Ulmert, D, Serio, A, Björk, T, Scardino, P, Eastham, J, Berglund, G, Lilja, H

miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. by Hagman, Z, Larne, O, Edsjö, A, Bjartell, A, Ehrnström, R, Ulmert, D, Lilja, H, Ceder, Y

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential... by Ulmert, D, Vickers, A, Scher, H, Becker, C, Iversen, P, Frankel, D, Jensen, J, Olesen, T, Lilja, H

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. by Lilja, H, Ulmert, D, Björk, T, Becker, C, Serio, A, Nilsson, J, Abrahamsson, P, Vickers, A, Berglund, G

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study by Vickers, A, Cronin, A, Björk, T, Manjer, J, Nilsson, P, Dahlin, A, Bjartell, A, Scardino, P, Ulmert, D, Lilja, H

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. by Vickers, A, Cronin, A, Björk, T, Manjer, J, Nilsson, P, Dahlin, A, Bjartell, A, Scardino, P, Ulmert, D, Lilja, H

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study. by Ulmert, D, Cronin, A, Björk, T, O'Brien, M, Scardino, P, Eastham, J, Becker, C, Berglund, G, Vickers, A, Lilja, H

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. by Lilja, H, Cronin, A, Dahlin, A, Manjer, J, Nilsson, P, Eastham, J, Bjartell, A, Scardino, P, Ulmert, D, Vickers, A

Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or... by Ulmert, D, Serio, A, O'Brien, M, Becker, C, Eastham, J, Scardino, P, Björk, T, Berglund, G, Vickers, A, Lilja, H

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening. by Vickers, A, Gupta, A, Savage, C, Pettersson, K, Dahlin, A, Bjartell, A, Manjer, J, Scardino, P, Ulmert, D, Lilja, H

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. by Ulmert, D, Evans, M, Holland, J, Rice, S, Wongvipat, J, Pettersson, K, Abrahamsson, P, Scardino, P, Larson, S, Lilja, H, Lewis, J, Sawyers, C

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. by Klein, R, Hallden, C, Gupta, A, Savage, C, Dahlin, A, Bjartell, A, Manjer, J, Scardino, P, Ulmert, D, Wallström, P, Vickers, A, Lilja, H

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antige... by Evans-Axelsson, S, Ulmert, D, Örbom, A, Peterson, P, Nilsson, O, Wennerberg, J, Strand, J, Wingårdh, K, Olsson, T, Hagman, Z, Tolmachev, V, Bjartell, A, Lilja, H, Strand, SE

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index. by Ulmert, D, Kaboteh, R, Fox, J, Savage, C, Evans, M, Lilja, H, Abrahamsson, P, Björk, T, Gerdtsson, A, Bjartell, A, Gjertsson, P, Höglund, P, Lomsky, M, Ohlsson, M, Richter, J, Sadik, M, Morris, M, Scher, H, Sjöstrand, K, Yu, A, Suurküla, M, Edenbrandt, L, Larson, S